NO994257L - Anvendelse av levobupivakain ved ansiktskirurgi - Google Patents

Anvendelse av levobupivakain ved ansiktskirurgi

Info

Publication number
NO994257L
NO994257L NO994257A NO994257A NO994257L NO 994257 L NO994257 L NO 994257L NO 994257 A NO994257 A NO 994257A NO 994257 A NO994257 A NO 994257A NO 994257 L NO994257 L NO 994257L
Authority
NO
Norway
Prior art keywords
levobupivacaine
facial surgery
facial
surgery
ophthalmics
Prior art date
Application number
NO994257A
Other languages
English (en)
Other versions
NO994257D0 (no
NO322446B1 (no
Inventor
Brian Albert Gennery
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of NO994257D0 publication Critical patent/NO994257D0/no
Publication of NO994257L publication Critical patent/NO994257L/no
Publication of NO322446B1 publication Critical patent/NO322446B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO19994257A 1997-03-03 1999-09-02 Anvendelse av levobupivakain ved fremstilling av et medikament NO322446B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9704352.5A GB9704352D0 (en) 1997-03-03 1997-03-03 Levobupivacaine and its use
PCT/GB1998/000657 WO1998038996A1 (en) 1997-03-03 1998-03-03 The use of levobupivacaine in facial surgery

Publications (3)

Publication Number Publication Date
NO994257D0 NO994257D0 (no) 1999-09-02
NO994257L true NO994257L (no) 1999-11-02
NO322446B1 NO322446B1 (no) 2006-10-09

Family

ID=10808603

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994257A NO322446B1 (no) 1997-03-03 1999-09-02 Anvendelse av levobupivakain ved fremstilling av et medikament

Country Status (20)

Country Link
US (1) US5919804A (no)
EP (1) EP0981347B1 (no)
JP (1) JP2001513812A (no)
KR (1) KR100516676B1 (no)
CN (1) CN1089585C (no)
AT (1) ATE240730T1 (no)
AU (1) AU730390B2 (no)
BR (1) BR9808303A (no)
CA (1) CA2279497C (no)
DE (1) DE69814851T2 (no)
DK (1) DK0981347T3 (no)
ES (1) ES2199423T3 (no)
GB (1) GB9704352D0 (no)
HU (1) HU225151B1 (no)
IL (1) IL131084A0 (no)
NO (1) NO322446B1 (no)
PL (1) PL190900B1 (no)
PT (1) PT981347E (no)
WO (1) WO1998038996A1 (no)
ZA (1) ZA981779B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0998286A2 (en) * 1997-07-21 2000-05-10 Darwin Discovery Limited Use of levobupivacaine
ATE239474T1 (de) * 1997-07-22 2003-05-15 Darwin Discovery Ltd Verwendung von levobupivacain
JP4575592B2 (ja) 1997-11-14 2010-11-04 パシラ ファーマシューティカルズ インコーポレーテッド 多小胞リポソームの製造
WO2000003660A1 (en) 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
US20030096000A1 (en) * 2001-05-31 2003-05-22 Solis Rosa Maria Encapsulation of nanosuspensions in liposomes and microspheres
CN103143022A (zh) 2002-07-30 2013-06-12 奥默罗斯公司 眼科冲洗液及方法
DE10260313A1 (de) * 2002-12-20 2004-07-15 Siemens Ag Elektrische Maschine mit Wicklungen aus Litze
US20050176823A1 (en) * 2004-02-10 2005-08-11 Diaz Robert L. Intra-operative procedure for post-operative pain control
AU2013201465B2 (en) 2012-10-24 2016-03-03 Rayner Intraocular Lenses Limited Stable preservative-free mydriatic and anti-inflammatory solutions for injection
TWI705812B (zh) 2014-12-01 2020-10-01 奥默羅斯公司 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
GB2627096A (en) 2021-10-14 2024-08-14 Pacira Pharmaceuticals Inc Bupivacaine multivesicular liposome formulations and uses thereof
IL316770A (en) 2022-05-05 2025-01-01 Pfof Llc Nerve block anesthesia and method
US12070454B1 (en) 2022-05-05 2024-08-27 Pfof Llc Anesthetic nerve block and method
US12246092B1 (en) 2024-05-20 2025-03-11 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251468B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
ATE150643T1 (de) * 1993-10-13 1997-04-15 Chiroscience Ltd Analgetisches mittel und dessen verwendung
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
EP0821588B1 (en) * 1995-04-13 2003-06-18 Darwin Discovery Limited Levobupivacaine and its use as an anaesthetic in pregnant women

Also Published As

Publication number Publication date
HU225151B1 (en) 2006-07-28
HUP0000873A2 (hu) 2000-09-28
DE69814851T2 (de) 2004-01-22
JP2001513812A (ja) 2001-09-04
US5919804A (en) 1999-07-06
ES2199423T3 (es) 2004-02-16
BR9808303A (pt) 2000-05-16
NO994257D0 (no) 1999-09-02
CA2279497C (en) 2009-01-20
DK0981347T3 (da) 2003-09-15
ATE240730T1 (de) 2003-06-15
AU730390B2 (en) 2001-03-08
AU6630498A (en) 1998-09-22
CA2279497A1 (en) 1998-09-11
IL131084A0 (en) 2001-01-28
CN1089585C (zh) 2002-08-28
NO322446B1 (no) 2006-10-09
PL190900B1 (pl) 2006-02-28
EP0981347A1 (en) 2000-03-01
DE69814851D1 (de) 2003-06-26
EP0981347B1 (en) 2003-05-21
ZA981779B (en) 1999-03-03
HK1022651A1 (en) 2000-08-18
WO1998038996A1 (en) 1998-09-11
KR100516676B1 (ko) 2005-09-22
PL335561A1 (en) 2000-05-08
HUP0000873A3 (en) 2002-10-28
CN1249684A (zh) 2000-04-05
KR20000075896A (ko) 2000-12-26
GB9704352D0 (en) 1997-04-23
PT981347E (pt) 2003-09-30

Similar Documents

Publication Publication Date Title
NO994257D0 (no) Anvendelse av levobupivakain ved ansiktskirurgi
ZA981780B (en) The use of levobupivacaine in paediatric surgery
DE69814394D1 (de) Verwendung von levobupivacain
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
ZA955327B (en) New pharmaceutical preparation for pain management
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
ATE219929T1 (de) Hautbleichende dermatologische und/oder kosmetische zusammensetzung
DK1052973T3 (da) Transmucosale formuleringer af levosimendan
PT888114E (pt) Utilizacao de (+)-alfa-(2,3-dimetoxifenil)-1-¬2-(4-fluorofenil)etil|-4-piperidinometanol no tratamento de doencas depressivas e doencas bipolares
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
IT242240Y1 (it) Schema anatomico del viso di una persona
UA9672A (uk) Спосіб лікування деструктивних форм гострого панкреатиту
AR029326A1 (es) Uso de la levobupivacaina para la preparacion de medicamentos de aplicacion en la anestesia de pacientes que no requieren hospitalizacion prequirurgica mayor de 12 horas, luego de la perdida del bloqueo motor

Legal Events

Date Code Title Description
MK1K Patent expired